Delayed
Hong Kong S.E.
04:40:03 08/05/2024 BST
|
5-day change
|
1st Jan Change
|
3.2
HKD
|
0.00%
|
|
+0.31%
|
-2.74%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
9,503
|
9,501
|
17,112
|
11,917
|
13,192
|
13,008
|
-
|
-
|
Enterprise Value (EV)
1 |
9,503
|
9,501
|
17,112
|
11,917
|
13,192
|
13,008
|
13,008
|
13,008
|
P/E ratio
|
-
|
5.53
x
|
-
|
6.36
x
|
15.9
x
|
3.8
x
|
3.4
x
|
-
|
Yield
|
4.2%
|
5.58%
|
4.84%
|
-
|
-
|
4.75%
|
5.44%
|
5.78%
|
Capitalization / Revenue
|
0.5
x
|
0.48
x
|
0.45
x
|
-
|
0.29
x
|
0.25
x
|
0.2
x
|
0.19
x
|
EV / Revenue
|
0.5
x
|
0.48
x
|
0.45
x
|
-
|
0.29
x
|
0.25
x
|
0.2
x
|
0.19
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
3.18
x
|
6.85
x
|
6.19
x
|
5.66
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.4
x
|
1.17
x
|
1.5
x
|
-
|
1.04
x
|
0.95
x
|
0.68
x
|
0.77
x
|
Nbr of stocks (in thousands)
|
4,090,000
|
4,090,000
|
4,440,000
|
4,424,126
|
4,411,535
|
4,405,686
|
-
|
-
|
Reference price
2 |
2.600
|
2.760
|
4.730
|
3.050
|
3.290
|
3.200
|
3.200
|
3.200
|
Announcement Date
|
30/03/20
|
26/03/21
|
25/03/22
|
30/03/23
|
14/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,842
|
19,785
|
38,430
|
-
|
46,066
|
52,800
|
65,324
|
67,600
|
EBITDA
1 |
-
|
-
|
-
|
-
|
4,142
|
1,900
|
2,100
|
2,300
|
EBIT
1 |
1,584
|
2,109
|
3,656
|
-
|
1,808
|
1,200
|
3,228
|
1,600
|
Operating Margin
|
8.41%
|
10.66%
|
9.51%
|
-
|
3.92%
|
2.27%
|
4.94%
|
2.37%
|
Earnings before Tax (EBT)
1 |
-
|
1,998
|
3,198
|
-
|
681.7
|
4,002
|
4,480
|
-
|
Net income
1 |
-
|
1,700
|
2,613
|
1,855
|
860.8
|
3,395
|
3,800
|
-
|
Net margin
|
-
|
8.59%
|
6.8%
|
-
|
1.87%
|
6.43%
|
5.82%
|
-
|
EPS
2 |
-
|
0.4988
|
-
|
0.4798
|
0.2066
|
0.8420
|
0.9410
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1092
|
0.1540
|
0.2288
|
-
|
-
|
0.1520
|
0.1740
|
0.1850
|
Announcement Date
|
30/03/20
|
26/03/21
|
25/03/22
|
30/03/23
|
14/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
20.4%
|
20.9%
|
27.2%
|
-
|
6.88%
|
8.27%
|
12.6%
|
8.78%
|
ROA (Net income/ Total Assets)
|
6.37%
|
7.66%
|
8.53%
|
-
|
-
|
2.1%
|
2.12%
|
2.47%
|
Assets
1 |
-
|
22,197
|
30,630
|
-
|
-
|
161,667
|
179,245
|
-
|
Book Value Per Share
2 |
1.860
|
2.360
|
3.150
|
-
|
3.170
|
3.360
|
4.720
|
4.150
|
Cash Flow per Share
2 |
-
|
-
|
-
|
-
|
0.5400
|
0.3700
|
1.090
|
0.3800
|
Capex
1 |
1,666
|
1,801
|
3,430
|
-
|
-
|
200
|
2,150
|
400
|
Capex / Sales
|
8.84%
|
9.11%
|
8.92%
|
-
|
-
|
0.38%
|
3.29%
|
0.59%
|
Announcement Date
|
30/03/20
|
26/03/21
|
25/03/22
|
30/03/23
|
14/03/24
|
-
|
-
|
-
|
Average target price
5.34
HKD Spread / Average Target +66.87% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.74% | 1.8B | | +4.46% | 102B | | -3.35% | 65.27B | | +46.67% | 41.44B | | +19.71% | 40.05B | | +6.70% | 32.48B | | +11.78% | 19.71B | | +17.06% | 17.33B | | +20.73% | 15.6B | | +11.69% | 15.34B |
Other Commodity Chemicals
|